Description
SARS-CoV-2 Nucleocapsid Protein (E9L7H) XP® Rabbit mAb recognizes endogenous levels of total SARS-CoV-2 nucleocapsid (N) protein. The antibody has been confirmed to detect the following SARS-CoV-2 isolates and variants: USA-WA1/2020, Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), Delta (B.1.617.2), and Omicron (B.1.1.529). The antibody does not cross-react with nucleocapsid (N) protein from SARS-CoV-1 coronavirus. Monoclonal antibody is produced by immunizing animals with recombinant protein specific to the amino terminus of SARS-CoV-2 nucleocapsid (N) protein (USA-WA1/2020 isolate).
Target
Nucleocapsid Protein SARS-CoV-2
Target Alias Names
N, Nucleocapsid Protein
Isotype/Mimetic
IgG
Animal-Derived Biomaterials Used
BSA
Sequence Available
Yes
Original Discovery Method
Immunization
Antibody/Binder Origins
Animal-dependent discovery, post-2020, In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation